| Primary |
| Drug Use For Unknown Indication |
14.1% |
| Back Pain |
10.9% |
| Depression |
10.9% |
| Pain |
10.9% |
| Intentional Overdose |
9.4% |
| Headache |
7.8% |
| Osteoarthritis |
6.3% |
| Diarrhoea |
4.7% |
| Abdominal Pain Upper |
3.1% |
| Cough |
3.1% |
| Migraine |
3.1% |
| Product Used For Unknown Indication |
3.1% |
| Abdominal Pain |
1.6% |
| Antiplatelet Therapy |
1.6% |
| Autoimmune Disorder |
1.6% |
| Folate Deficiency |
1.6% |
| Local Swelling |
1.6% |
| Mastectomy |
1.6% |
| Parkinson's Disease |
1.6% |
| Post Procedural Infection |
1.6% |
|
| Overdose |
10.7% |
| Pancreatitis Acute |
10.7% |
| Vomiting |
10.7% |
| Pain |
7.1% |
| Urticaria |
7.1% |
| Completed Suicide |
3.6% |
| Constipation |
3.6% |
| Dermatitis Exfoliative |
3.6% |
| Dysphagia |
3.6% |
| Feeling Abnormal |
3.6% |
| Hallucination |
3.6% |
| Incoherent |
3.6% |
| Inflammation |
3.6% |
| Jaundice Cholestatic |
3.6% |
| Lactose Intolerance |
3.6% |
| Malaise |
3.6% |
| Multiple Drug Overdose |
3.6% |
| Neck Pain |
3.6% |
| Neuroleptic Malignant Syndrome |
3.6% |
| Respiratory Depression |
3.6% |
|
| Secondary |
| Pain |
35.9% |
| Product Used For Unknown Indication |
10.2% |
| Osteoarthritis |
5.8% |
| Migraine |
5.5% |
| Depression |
4.8% |
| Fibromyalgia |
4.1% |
| Sleep Disorder Therapy |
4.1% |
| Drug Use For Unknown Indication |
3.6% |
| Rheumatoid Arthritis |
3.3% |
| Asthma |
3.1% |
| Osteoporosis |
2.4% |
| Prophylaxis |
2.3% |
| Hypermobility Syndrome |
2.3% |
| Myalgia |
2.3% |
| Constipation |
2.2% |
| Ill-defined Disorder |
2.1% |
| Withdrawal Syndrome |
2.0% |
| Analgesic Therapy |
1.6% |
| Headache |
1.3% |
| Deep Vein Thrombosis |
1.2% |
|
| Somnolence |
11.7% |
| Drug Hypersensitivity |
9.5% |
| Drug Intolerance |
7.3% |
| Toxicity To Various Agents |
6.6% |
| Vomiting |
6.6% |
| Cerebrovascular Accident |
5.8% |
| Dyspnoea |
5.8% |
| Suicidal Ideation |
5.1% |
| Erythema Multiforme |
4.4% |
| Haemorrhage Subcutaneous |
4.4% |
| Nausea |
4.4% |
| Withdrawal Syndrome |
4.4% |
| Dizziness |
3.6% |
| Platelet Count Increased |
3.6% |
| Urticaria |
3.6% |
| Drug Exposure During Pregnancy |
2.9% |
| Eating Disorder |
2.9% |
| Weight Decreased |
2.9% |
| Dermatitis Exfoliative |
2.2% |
| Hepatitis Cholestatic |
2.2% |
|
| Concomitant |
| Prophylaxis |
21.3% |
| Product Used For Unknown Indication |
16.0% |
| Cough |
7.9% |
| Drug Use For Unknown Indication |
6.7% |
| Dehydration |
6.3% |
| Pain |
6.2% |
| Fluid Replacement |
4.9% |
| Medication Dilution |
4.9% |
| Constipation |
4.7% |
| Chemotherapy |
3.4% |
| Depression |
3.1% |
| Cancer Pain |
2.2% |
| Therapeutic Procedure |
2.1% |
| Rheumatoid Arthritis |
2.0% |
| Prophylaxis Of Nausea And Vomiting |
1.8% |
| Perineal Pain |
1.4% |
| Spinal Column Stenosis |
1.4% |
| Hypertension |
1.2% |
| Mineral Supplementation |
1.2% |
| Plasma Cell Myeloma |
1.1% |
|
| Vomiting |
27.0% |
| Pneumonia |
7.4% |
| Interstitial Lung Disease |
6.1% |
| Somnolence |
5.5% |
| Pyrexia |
5.3% |
| Wound Infection |
5.3% |
| Lung Neoplasm Malignant |
4.4% |
| Loss Of Consciousness |
3.7% |
| Rhabdomyolysis |
3.5% |
| Sepsis |
3.5% |
| International Normalised Ratio Increased |
3.1% |
| Platelet Count Decreased |
3.1% |
| Dyspnoea |
2.9% |
| Lung Disorder |
2.9% |
| Death |
2.8% |
| Renal Failure Acute |
2.8% |
| Sinus Tachycardia |
2.8% |
| Vena Cava Thrombosis |
2.8% |
| Pulmonary Embolism |
2.6% |
| Weight Decreased |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
59.5% |
| Bipolar Disorder |
10.8% |
| Systemic Candida |
10.8% |
| Diarrhoea |
5.4% |
| Hypothyroidism |
5.4% |
| Anal Candidiasis |
2.7% |
| Cough |
2.7% |
| Lower Respiratory Tract Infection |
2.7% |
|
| International Normalised Ratio Increased |
50.0% |
| Somnolence |
33.3% |
| Vomiting |
16.7% |
|
